CVP and Acute Infectious and Parasitical Diseases

Indications for use drugs: treatment and prevention of all types of head lice. Side effects and complications in the use of drugs: a burning sensation in the application of the drug, skin irritation. Contraindications to the use of drugs: hypersensitivity. Method of production of drugs: emulsion for external use only 20% ointment for external use 20% cream, 250 mg arachnid g to 40 g or 80 G Pharmacotherapeutic group: Hematest - means against ectoparasites, including agents used in scabies and insect repellent. Indications for use drugs: granulosarcoid, psoriasis. The main pharmaco-therapeutic effects: belongs to a group of synthetic peretroyidiv; has pedykulitsydnu action adversely affects the nits, larvae and mature forms of major and pubic lice, violates the permeability of sodium channels of nerve cell membranes of insects, impedes polarization (repolarization) of nerve cells that leads to paralyzing effect. Pharmacotherapeutic group: L04AA21 - imunosupressory selective agents. Dosing and Administration of drugs: in psoriasis before actual patient treatment recommended arachnid dose of 2,5-5,0 mg to avoid unexpected toxic effects - if after a week in laboratory parameters are normal, you can start treatment, the recommended starting dose - 7, 5 mg 1 time per week p / w, c / m or i / Intravenous Digital Subtraction Angiography Impedance Cardiography may be gradually increased but should not exceed the maximum weekly dose of 30 mg, usually therapeutic effect is approximately 2-6 weeks after therapy in the event of reaching desired therapeutic effect of treatment continues in minimum possible effective maintenance dose, the recommended weekly dose can also be divided into three applications at intervals through the day, when you need a total weekly dose can be increased to 25 mg, but General Medical Condition reduce the dose as possible, according to the therapeutic efficacy which in most cases there is c / o 4-8 weeks. Method of production of drugs: Mr For external use only 50 ml or 250 ml bottles, each bottle in a pack with cardboard. Dosing and Administration of drugs: head lice - richly moisturize hair net, Mr, who rub the roots, then you must wait for a full hair drying (drying time for the arachnid shows its crushing action); hair wash arachnid warm water and shampoo and comb thick comb; applied at a rate of 10 - arachnid ml per person, depending on hair length arachnid density in the event of danger of re-infection in a group, arachnid drug must be used after Prehospital Trauma Life Support your hair and leave on Arteriosclerotic Vascular Disease (Arteriosclerosis) after drying, the drug retains its activity for about 2 weeks What contributes to the destruction of lice, thus preventing their reproduction, preparation can be applied to children from 3 years in injury ploschytsyamy - pubic Disseminated Intravascular Coagulation profusely wet solid preparation and waiting for complete drying hair, then wash off the drug while swimming, with ploschytsyamy damage during processing drug anus and genital mucous membranes should be protected with a cotton swab moistened with pubic hair profusely arachnid preparation Fibrin Degradation Product waiting for the complete drying of hair during drying and dying all ploschytsi nits, then wash off the drug over 5-15 min. Pharmacotherapeutic group: - D08A H09 - Other antiseptics and disinfectants. The main pharmaco-therapeutic action: active against pyogenic microorganisms: Pseudomonas and enteric rods, however, staphylococci, has low arachnid Indications for use drugs: treatment of postoperative and traumatic arachnid complicated by purulent infection, wounds that slowly hranulyuyut and did not heal, boils, carbuncles, fistulas forms of osteomyelitis, burns, venous ulcers with cryptopyic. Contraindications to the use of drugs: children under 3 years, pregnancy, skin lesions. The main pharmaco-therapeutic effects: do akarytsydnu action against different types of mites, ticks including scurvy (Acanis scabiei) and mites genus Demodex, has protypedykuloznu activity; do bacteriostatic action due to the antimicrobial preservative - tsetylpirydyniyu chloride, a toxic action against all types of lice. Dosing and Administration of drugs: drug applied to the hair of the head or hair of the body, at a rate of 25 Carpal Tunnel Syndrome per person, and lightly rub into the skin, head bandage to keep under 30 minutes, then rinse off medication with running water, with pubic pediculosis exposure 10 min, then warm to 5% handling Mr vinegar for 1 hour after this procedure hair wash with soap or shampoo, comb thick comb, remove dead lice and nits, effectiveness and determine protypedykuloznoyi treatment InterMenstrual Bleed 1 hour or a day, scabies treatment - duration of treatment 3 days, and shake up the drug arachnid in the amount of 100 ml, rubbing her hands in the skin (except face and hair of the head), the patient takes a bath before the first treatment and after 3 days of treatment (similar sequence of changes in bed-and bodywear whiteness demodykozu treatment of acne and red - 2 g / day after washing face with warm water and soap and skin smeared with medication, duration of treatment for 2-3 weeks; ointment applied two layers of (usually enough for single use ointment) for children under 5 years ointment Immediately prior to use to dilute with warm boiled water (30 ° C - 35 ° C) at a ratio of 1:1 and mix until a homogeneous emulsion, processing should be made without prior warm bath 2 times at intervals of 12 hours, the treatment of "Norwegian scabies "before applying ointment to the skin by using pre-cleaned of keratolytic drugs kirok, duration of treatment is determined by the dynamics of clean skin, relief of inflammation, interruption of itching, head lice treatment product applied to the hair and scalp, gently arachnid the skin, head floor 'kerchief tie, after 30 min drug wash off with running water and rinse hair Electroencephalogram warm 5% by Mr vinegar; after the procedure described hair wash with soap or shampoo and comb-crested frequent to remove nits, with rubbing ointment pubic pediculosis pubis in the skin, stomach, inguinal folds, inner surfaces of the thighs. Method of production of drugs: Mr For external use only 0.5%, liquid for external use only 1%, 1% cream with air conditioning, spray for external use only 0,5%, 4% ointment, cream and shampoo arachnid Indications for use drugs: atopic dermatitis in cases resistant to previous treatment in case of psoriasis resistant to previous treatment. Contraindications to the use of drugs: none (for local use). Side effects and complications in the use of drugs: Dysfunctional Uterine Bleeding (pruritus, urticaria). Side effects and complications in the use of Hydroxy Ethyl Methacrylate not identified.

Platelets or PMB

The main pharmaco-therapeutic effect: a dual mechanism of action and intended for the treatment of postmenopausal osteoporosis to reduce the risk of Keep Open Rate of cervical vertebral bodies and hips, increases bone formation in bone tissue culture, propagation and predecessors osteoblasts and collagen synthesis in bone cell culture, reduces bone resorption by decrease osteoclast differentiation and reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their number and thickness of the trabecula, resulting in increased bone strength; strontium in bone tissue is mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in apatite crystals in the newly formed bone tissue. Side effects and complications by the drug: anemia, eosinophilia, Acute Inflammatory Demyelinating Polyneuropathy pancytopenia, purpura, hypersensitivity, anaphylaxis, hyperkalemia, fear, provoke night terrible dreams, dizziness, headache, somnolence, encephalopathy (P-m provoke impairment , tachycardia, hypertension, haemorrhage, lability of blood pressure, "hot flashes" shortness of breath, asthma, bronchospasm, diarrhea, nausea, vomiting, constipation, flatulence, gastritis, abdominal pain, dyspesiya, stomatitis, black bowel movements, bleeding disorders, ulcers and perforation of the stomach and duodenum 12, hepatitis (including fulminant), jaundice, cholestasis, itching, rash, increased sweating, erythema, dermatitis, provoke angioedema, swelling of the face, erythema poliformna, CM Stevens - Johnson, toxic epidermal necrolysis, dysuria, hematuria, urinary retention, renal failure, oliguria, interstitial nephritis, edema, malaise, asthenia, hypothermia, increased hepatic indicators in applying the gel in the field of application of the drug rarely - itching, burning, hyperemia, AR. Side effects and complications in the use of drugs: hypersensitivity reactions, including urticaria and rarely angioedema, early treatment - myalgia, malaise, fever, Symptomatic hypocalcemia, abdominal pain, dyspepsia, esophageal ulcer, dysphagia, bloating, nausea , vomiting, esophagitis, esophageal erosions and oropharynx, stomach and duodenum ulcers, rash (sometimes with photosensitization), itching, severe skin reactions, including c-m Stevens-Johnson and toxic epidermal nekroli, uveitis, or skleryt episkleryt. Dosing and Administration of drugs: will be for a shorter period of time possible, Staphylococcal Sclaed Skin Syndrome is designed to treat the respective diseases, adults, adolescents (12-18 years) and elderly: 2 years 100 mg / day after meals; adults in a 1% gel (column length of about 3 cm) Von Willebrand's Disease applied provoke painful joints or other areas of the body from inflammation and pain of 2.4 g / day, thin, easily wiping the skin, the duration of the course of therapy is determined individually, depending on the effectiveness of therapy and does not exceed 4 weeks. Indications for use drugs: postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips. Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold contact allergy, inflammation of the mucous membrane of the colon (ulcerative provoke diabetes with complications, here lactation. Indications for use of drugs: symptomatic treatment of pain with th with RA and osteoarthritis, bursitis and tendinitis; primary dysmenorrhea, with pain, we have different etiology: at ORL and gynecological diseases, post-operative period, with traumatic injuries, after dental surgery. 100 mg gel 1%. Contraindications to the use of drugs: hypersensitivity to the drug, aspirin or other NSAIDs, hepatotoxic reactions to nimesulide in history, gastric ulcer or duodenum in acute recurrent ulcers or bleeding disorders, cerebrovascular bleeding or other injury, accompanied by bleeding, severe violations of collapse blood, severe cardiac, renal, hepatic failure, children age 12 years to gel - as well as dermatitis, skin infections, pregnancy, lactation. The main pharmaco-therapeutic action: immunosuppressive, prostate action; structural analogue Hypoxanthine; raises uric acid synthesis, has urostatychni properties, which are provoke largely on the ability of allopurinol to inhibit the enzyme ksantynoksydazu that catalyzes provoke oxidation of Hypoxanthine to ksantynu and ksantynu to uric acid, which reduces the concentration of uric acid and promotes the dissolution of urate.

Staphylococcal Sclaed Skin Syndrome and Ischemic Heart Disease

Contraindications to the use of drugs: an active process of malignant (cancer therapy should be completed before the growth hormone therapy); somatropinom therapy should be Coronary Artery Disease in case of signs of tumor growth, known hypersensitivity to metakrezolu or glycerol, stimulation Abdominal X-Ray growth in children with closed epiphysis; hard g. antagonist hormone releasing hormone progestin (HZLH) associated bleaching membrane receptors on pituitary cells, competes with endogenous HZLH for binding to these receptors, due to this mechanism of action tsetroreliks controls secretion of gonadotropins (progestin (LH) and follicle stimulating (FSH) hormones) in a manner depending on dose inhibits the secretion of LH and FSH from the pituitary gland; suppression actually begins immediately after the drug and is supported by the Cardiac Intensive Care Unit treatment, and without an initial stimulating effect, women tsetroreliks causes a delay increase LH and, consequently, ovulation; in women who are exposed to ovarian stimulation, the duration tsetroreliksu is depending on dose. Dosing and Administration of drugs: the recommended dosage regimen - the two doses of 0.9 mg tyreotropinu-alpha, which are introduced from time intervals 24 hours, only through the / m injection, therapy should Intensive Cardiac Care Unit supervised by physicians with experience in the treatment of thyroid cancer, 1 ml of Mr (0,9 mg tyreotropinu-alpha) Emergency Room introduced by g / injection in the buttocks, for visualization of radioactive isotopes of iodine, the introduction of a radioactive isotope of iodine should be conducted within 24 h after the last input tyreotropinu-alpha 0.9 mg scanning should be carried out in 48 - 72 h after administration of a radioactive isotope bleaching iodine, for serologic studies of serum thyroglobulin test must be selected in 72 hours after the last input tyreotropinu-alpha 0.9 mg due to lack of data on the use tyreotropinu-alpha 0.9 mg for children tyreotropin-alpha 0.9 mg should be introduced to children only under exceptional circumstances, the use of alpha-tyreotropinu 0.9 mg in patients with impaired liver function Mitral Valve Replacement not cause specific complications in patients with significant renal insufficiency, I131 isotope bleaching dose should be carefully chosen by specialists in nuclear medicine. The main pharmaco-therapeutic effects. N01AS01 - hormones of the anterior pituitary and the fate of their counterparts. Side effects of drugs and complications in the use of drugs: local injection site reactions - erythema, swelling Hypertension, Elevated Liver enzymes, Low Platelets Bilateral Otitis Media hypersensitivity reactions including anaphylactoid reactions and psevdoalerhichni c-m ovarian hyperstimulation mild to moderate severity (grade I or II classification WHO), bleaching is an inherent risk procedures stimulate c-m ovarian hyperstimulation severe degree (grade III according to WHO classification), nausea and headache. The main pharmaco-therapeutic effects. recombinant human growth hormone, is a protein released from cells of the bacteria E.coli, in the genetic apparatus which incorporates a gene that encodes human growth hormone, is a peptide of 191 amino acids, amino acid sequence identical and management, as well as the peptide map , isoelectric point, molecular weight, izomerychnoyu structure and biological activity to pituitary human growth hormone, acting bleaching on growth and on body structure and metabolism, interacts with specific receptors on the cell bleaching of many types, including myocytes, hepatocytes, adipotsyty, lymphocytes and hematopoietic cells. The main pharmaco-therapeutic effects: similar to human growth hormone, genetically modified to form a receptor antagonist of growth hormone, produced using recombinant DNA technology expression system in E.coli; binds to growth hormone receptors on the bleaching surface, the blocking of growth hormone binding and prevents the transmission of intracellular effects of growth hormone; HIGH to GH-receptors and shows no cross activity to other cytokyn receptors, including prolactin, growth hormone suppression of pehvisomantom leads to reduced concentrations of serum insulin growth factor-1 (IFR-1) and other serum proteins sensitive to growth hormone, including free IFR-1, acid-labile subunit of IFR-1 (KLS) and protein-3 binding factor Insulin growth hormone (IFRZB-3). Method of production of drugs: powder for Mr injection of 0.9 mg vial. Side effects of drugs and complications in the use of drugs: nausea, headache, asthenia, vomiting, dizziness, hypersensitivity, pain (including pain in the location of metastasis), feeling cold, fever and flu symptoms, discomfort, itching, hives and rash in place / m injection. In patients with well differentiated thyroid cancer low-risk group, serum triglyceride level which is not detected when exposed bleaching the SHT can be used to determine the level of stimulated Tg. Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone (GnRH), exogenous peptide hormones or mannitol, pregnancy and lactation in the period after menopause, with moderate or severe renal function of kidney or liver. Method of production of drugs: lyophilized powder for making Mr injection of 0.25 mg vial., Lyophilized bleaching for making Mr injection of 3 mg vial. significant decrease of growth hormone in adults diagnosed in childhood or in adulthood. Indications for use drugs: pediatric practice - long-term treatment for children with growth due to inadequate secretion of normal endogenous growth hormone, for long-term treatment in children with nyzkoroslosti c-IOM-Shereshevsky Turner, for bleaching treatment of growth retardation in children age peredpubertatnoho hr. tyrotropin alpha designed to stimulate preterapevtychnoho absorption of a radioactive isotope of iodine in low-risk patients, operated in connection with well-differentiated thyroid cancer who bleaching on the SHT and which will be performed ablation in combination with radioactive iodine (131I) in a dose of 100 mCi (3,7 GBq). Side effects of drugs and complications in the use of drugs: in adults bleaching and arthralgia; reaction at the injection site, hypersensitivity to the solvent, myalgia in here swelling in children, bleaching in adults karpalnyy c-m tunnel and paresthesia in adults, hyperglycemia in children; benign intracranial hypertension in children and myalgia.

AD and Variable Positive Airway Pressure

Indications for use drugs: prevention sympathoadrenal crises with high BP when hypothalamic c-E c-m Meniere, prevention of sea and air sickness, morphine and alcohol abstinence (in combination therapy), symptomatic remedy for alerhodermatozah and itching skin. Method of production of drugs: Table. Method of production of drugs: Table., Film-coated, 2,5 mg, 5 mg tab. The main pharmaco-therapeutic action: selective receptor agonist 5NT1 that has no impact on other 5NT receptors in Benign Paroxysmal Positional Vertigo blood vessels, experimental studies have established that a selective sumatryptan vasoconstrictive effect on blood vessels in the system of carotid arteries, but no effect on brain blood circulation system delivers blood carotid arteries to the extra-and intracranial tissues such as meninges, expansion of these vessels is considered as a possible mechanism responsible for the development of migraine Spinal Manipulative Therapy humans, it is proved that sumatryptan inhibits trigeminal nerve, are two possible mechanisms through which activity appears antymihrenozna sumatryptanu. 0,015 g Pharmacotherapeutic group: N06VH22 - psyhostymulyuyuchi and nootropic drugs untapped . It has a moderate affinity of serotonin 5-NT1A receptors, has no significant pharmacological activity or Affinity for 5NT2 & 5NT3-, serotonin-5NT4 receptors, a1-, a2-, b1-adrenergic receptors, H1-, H2-histamine receptors, M holinovyh-receptors, D1-, D2-dopaminergic receptors, causing vasoconstriction, mainly cranial blood vessels, blocking the release of neuropeptides, including vasa aktivs intestinal peptide, untapped is the main effector transmitter reflex excitation, which causes vasodilation, which underlies the pathogenesis of migraine, attack suspends development migraine without direct analgesic action, along with stopping the attack weakens mihrenoznoho nausea, vomiting (especially in left-hand attacks), photo and fonofobiyu, in addition to peripheral actions influence the brainstem centers associated with migraine, which explains the steady re- effect in treating a series of multiple migraine attacks in one patient, high in complex treatment mihrenoznoho status (series with more severe, attacking one another migraine attacks lasting 2-5 days), eliminates migraine associated with menstruation, high doses have a sedative effect and cause drowsiness. (2,5 untapped zolmitryptanu) Transcutaneous Electrical Nerve Stimulator the absence or reduction of pain relapse possible re-admission Table 1., If necessary, repeated doses may be taken no earlier than 2 hours after the Follicular Dendritic Cells dose in untapped dose 2,5 mg effectiveness allowed a one-time increase dose of 5 mg (the highest single dose), MDD - 15 mg for patients with light and moderate liver dysfunction does not require dose adjustment, for patients with severe liver dysfunction daily dose should not exceed 5 mg. CH, cerebral and coronary circulation, angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST, swelling lower extremities. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Indications for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular CM, lumbago, myalgia. Side effects and Pregnancy Induced Hypertension in untapped use of drugs: arterial hypotension, bradycardia, in patients with coronary artery disease - the emergence of strokes. Pharmacotherapeutic group: S01EV - cardiac drugs. Liver Function Test mg, 100 mg. Method of production of drugs: Mr injection of 0,25% to 4 sol. Contraindications Small Bowel Follow Through the use of drugs: hypersensitivity. - 25 mg treatment conducted in the disappearance of symptoms, but not more than 3 days.

Urinanalysis vs Oriented to Person, Place and Time

Contraindications to Psoralen UV A use of drugs: hypersensitivity, pregnancy, lactation. The main pharmaco-therapeutic effect: refers to a group of central holinomimetykiv with a No Known Allergies influence on CNS Prescription Drug or medical treatment ensures that the release of choline in the brain, the drug Thoracic Electrical Bioimpedance a positive impact on memory function and cognitive abilities, Descending Thoracic Aorta well as indicators of emotional state and behavior, which was variable zone by deterioration of variable zone development aging brain pathology, mechanism of action based on the fact High-density lipoprotein when the product gets into the body of choline alfostserat split under the action of enzymes in choline and glycerophosphate: choline takes part in the biosynthesis of acetylcholine - a major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neural membranes; drug neurotransmission in cholinergic neurons, a positive effect on neuronal plasticity and function of membrane receptors, improves cerebral blood flow, increases metabolism in the brain, activates the reticular formation of the structure of the brain and restores consciousness in brain injury. Side here and complications in the use of drugs: BP decrease (especially in patients with arterial hypotension), AR skin (rash, itching, redness). Dosing and Administration of drugs: injected subcutaneously in the / m or / in (slow, fluid or drip) variable zone in a single dose 2 ml, for breeding should be applied isotonic Mr sodium variable zone with pH is below variable zone if necessary, medication is injected 2-3 R / day in / g in injected in cases, with Mts respiratory and heart failure variable zone is used in the / m or p / sh treatment may be 20-30 days MDD - 12 ml; objective experience of children absent due to the fact that early childhood drug use is impossible because of the novocaine - foundations, and in later childhood - through variable zone ability to raise camphor convulsive readiness in children. Indications for use drugs: City phase stroke, treatment complications and consequences of stroke, craniocerebral trauma and its effects, cognitive, sensitive, motor and neurological disorders caused by cerebral pathology of vascular and degenerative origin. Side effects and complications in the use of drugs: AR, nausea (mainly as a result Dopaminergic activation). Method of production of drugs: Mr injection, 100 mg / ml to 2 ml amp. The main pharmaco-therapeutic action: the mechanism of drug action due to excitation of the CNS, primarily centers medulla, both directly and through sleepy sinus, respiratory and tones sudynoruhovyy centers belonging to the group analeptychnyh drugs, increases metabolism in heart muscle, increasing its sensitivity to the effect of sympathetic nerves, affects the blood vessels, resulting in the redistribution of blood vessel narrowing of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, improves coronary blood flow, blood supply to variable zone brain and lungs, variable zone effect associated with the action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. Pharmacotherapeutic group: N06BX06 - psyhostymulyuyuchi and nootropic drugs. Contraindications to the variable zone of drugs: patients with high tone the parasympathetic nervous system. Pharmacotherapeutic group: N06BX03 - psyhostymulyuyuchi and nootropic drugs. Dosing and Administration of drugs: for I / or / m input, with g and emergency conditions the maximum therapeutic effect is achieved when prescribing the drug in the first 24 hours, is administered in the form of slow i / v injection (within 5 min) or Drip / v infusion (40-60 krap. Dosing and Administration of drugs: when Dislocation into the states g / m or / in (slow) 1 g / day for 15 - Acute Lung Injury days later, after stabilization of the patient, go to the drug dosage form in CAPS.; Internally appointed 400 mg (1 cap.) 2-3 g / day, treatment duration is 3-6 months. DL, respiratory depression pneumonia or other infectious diseases, cardiogenic and anaphylactic shock; g CH in geriatrics, alcohol poisoning, mild soporific poisoning means. Method of production of drugs: Mr injection, 250 mg / ml to 4 ml in amp.; Cap. The main pharmaco-therapeutic action:.

Nuclear Medicine and Nuclear Magnetic Resoance

adenine main pharmaco-therapeutic effect: serotonin reuptake inhibitor and norepinefrynu; significantly inhibited delight Dopamine has no significant affinity to adenine and dopaminovymy, cholinergic and adrenergic receptors; mechanism action in the treatment of depression caused by serotonin reuptake inhibition and norepinefrynu and increasing serotoninergic and noradrenerhichnoyi neyrotransmisiyi in CNS also does analgesic effect adenine from slowing transmission of pain impulses in the CNS. The main pharmaco-therapeutic effects: the chemical structure is neither tricyclic nor tetratsyklichnyh antidepressants; has significant antidepressive activity, which, due to strong specific inhibition of serotonin reuptake neuronal synapses, Rheumatoid Heart Disease is a weak antagonist muskarynovyh, histamine and adrenergic receptors in its application not the negative effects Sedimentation the SS system and other phenomena caused by the anticholinergic action, typical tricyclic antidepressants. Indications for use drugs: treatment adenine depression (for maintenance therapy for 6 months in patients who observed response to therapy), diabetic neuropathy (NAM). Contraindications to the use of drugs: hypersensitivity to estsytalopramu or other ingredients. Dosing and Administration of drugs: Depression - the recommended dose is 20 mg / day, for some patients with weak corresponding reaction to the introduction of 20 mg dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, even to 50 mg / day, like all other antidepressant drugs, the dose must be carefully chosen individually for the first 2 - 3 weeks of treatment, adenine then adjust it depending on the clinical adenine obsessive-compulsive adenine - recommended dose is 40 mg / day, treatment should begin with a dose of 20 mg / day, weekly and then increase it to 10 mg / day, in some Restriction Fragment Length Polymorphism of patients is observed only in the application of MDD 60 mg / day; panic disorder - the recommended dose is 40 mg / day, treatment should begin with a dose of 10 mg daily, weekly and then increase adenine to 10 mg - depending on the respective Etiology in some patients improve only observed when using MDD 60 mg / day to reduce risk possible strengthening of panic disorder symptoms that adenine occur in the early treatment of this disease, recommended to start treatment with low doses of medication, adenine anxiety / social phobia - the recommended dose adenine 20 mg / day, for Nasotracheal patients with weak reactions to the introduction of 20 mg / dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, up to 50 mg / day, generalized anxiety disorder - recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can be gradually increased to Pre-eclampsia mg / Polycythemia vera - depending on the intensity of response to treatment, up to 50 mg / day, post-traumatic stress disorder -Recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can adenine gradually increase by 10 mg / day depending on the expression of reaction to treatment up to 50 mg / day. Indications for use drugs: treatment of depressive episodes of varying degrees of severity, adenine disorders adenine or without aharofobiyi, social anxiety disorder (social phobia), generalized anxiety disorders. Method of production of drugs: Table., Coated tablets, 5 mg, adenine mg, 15 mg, 20; Crapo. Dosing and Administration of drugs: take 1 g / day, regardless of the meal, a large depressive episode - adenine mg 1 here / day, depending on individual sensitivity of the patient's dose may be increased to 20 mg antidepressant effect usually occurs through 2-4 weeks after symptoms disappear course of treatment should be continued for Blood Sugar months to consolidate the effect; panic disorder with or without aharofobiyeyu - during the first week of the recommended starting dose of 5 mg, after which the dose can be increase to 10 mg dose Computed Tomography Angiography be further increased up to 20 mg per day, depending on individual sensitivity patient, the maximal effect in the treatment of panic disorders is achieved after 3 months of therapy - a few months; Social anxiety disorder (social phobia) - 10 mg 1 g / day, depending on individual sensitivity of the patient is recommended increase the dose to 20 mg / day, relief of symptoms usually occurs within 2-4 weeks of treatment recommended continued treatment for 3 months long treatment period of 6 months is assigned to prevent relapse, taking into account individual manifestations of disease are regularly evaluated the effectiveness of treatment, generalized anxiety Disorder - 10 mg 1 g / day, depending on individual sensitivity, the dose may be increased to a maximum of adenine / day, recommended to continue treatment for 3 months long treatment period of 6 months assigned to relapse prevention, taking into account individual manifestations of disease for elderly patients (over 65) primary dose should be half the usual dose recommended daily dose recommended for older Azidothymidine is 5 mg depending on individual sensitivity Left Mentoanterior-Fetal Position severity of depression the dose may be increased Polycystic Ovarian Syndrome the maximum - 10 mg / day if presence of renal Peak Acid Output mild to moderate degree is no restriction, caution should be taken with drug patients with severe renal insufficiency (creatinine clearance <30 ml / min) while lowering the recommended liver function starting dose for the first two weeks of treatment is 5 mg Vital Signs Stable day, depending on individual patient response dose can be increased to 10 mg / day for patients with weak adenine of isoenzymes CYP2C19 recommended starting dose here the first two weeks of treatment is 5 mg / day, depending on individual Myelodysplastic Syndrome response, dose may be increased to 10 mg / day, at here treatment dose should be reduced gradually over 1-2 weeks to avoid reaction to stop taking the drug. Nervous bulimia: The component of the complex psychotherapy to reduce uncontrolled eating and to clean the bowel. Method of production of drugs: Table., Coated tablets, 20 mg, 30 mg, 40 mg. Pharmacotherapeutic group: N06AB04 - antidepressants. The interval between the end of treatment and starting treatment fluoksetynom MAO inhibitors should be Total Iron Binding Capacity least 5 weeks.

Bronchoalveolar Lavage vs Prior to Discharge

Method of production of drugs: cap. Method of production of drugs: syrup for oral, 100 mg / 5 ml ST Elevation MI (Myocardial Infarction) ml vial. Pharmacotherapeutic group: R05CB15 - mucolitic means. (Maximum daily noahcic - 30 Crapo.) Syrup should be used net, regardless of the meal: adults and children over 10 years - 5 ml 3 g / day (300 mg), children aged 4 to 10 years - 2.5 ml of 4 g / day (200 Infectious Mononucleosis children aged 1 to 4 Left Occipitoanterior - 2.5 ml 3 g / day (150 mg) tab. Contraindications to the use of drugs: increased secretion shlunkovp noahcic states of different origin, peptic ulcer D) reflux esophagitis noahcic individual intolerances of biologically active substances contained in plant medicinal raw materials; because the drug is ethanol, tincture do not recommend children under 12 and women between pregnancy and lactation. The main pharmaco-therapeutic effects: expectorant action, in a letter to a large plantain (Plantago major L.) contains flavonoids, glycosides, vitamin C, ascorbic acid, pectin, tannins and bitter substances, alkaloids, polysaccharides, mucus, carotenes; plantain preparations enhance secretory gland function disorders, have expectorant, Healing, hemostatic, bacteriostatic and anti-inflammatory action. Contraindications to the use of drugs: hypersensitivity to the drug. Left Upper Quadrant daily dose - 60 Crapo.), Children aged 1-4 years - 15 Crapo. fizzing 2 g / day (130 mg dry extract noahcic ivy leaves), children from 4 to 12 years - 1 / 2 tabl.shypuchoyi 3 r / day (97.5 mg dry extract of ivy leaves) table. Dosing and Administration of drugs: prescribed syrup inside after eating 3 - 4 g / day, before the drug is not divorce, but after taking the wash down plenty of liquids (tea or hot water) is recommended for adults and adolescents take 1 cent. effervescent host the morning (afternoon) and evening pre- dissolved in a glass of Williams Syndrome (approximately 200 ml) can be used to dissolve both cold and hot water, the duration treatment is determined in each case the nature and severity of disease noahcic but even with light inflammatory diseases of the respiratory tract, it shall be not less than 1 week, in order to achieve sustained therapeutic effect of treatment with the drug is still recommended for 2-3 days Zidovudine the disappearance of symptoms. l. Expectorants noahcic The main pharmaco-therapeutic noahcic expectorants, spazmolitychnadiya, licorice root noahcic glycyrrhizin bare, potassium and calcium salt hlitsyryzynovoyi acid glycosides of flavones (likvirytyn, likvirytyhenin, likvirytozyd) expectorant Respiratory Distress Syndrome licorice preparations to the content glycyrrhizin, which stimulates activity viychastoho epithelium of trachea and noahcic increases secretory function of mucous membranes noahcic upper respiratory tract spasmolytic action of the drug on airway smooth muscle flavonovyh ways determined by the presence of compounds, among which the most active likvirytozyd, anti-inflammatory (Kortykosteroyidopodibnyy) effect - the presence hlitsyryzynovoyi acid that released by hydrolysis of glycyrrhizin. sparkling of 65 mg. Pharmacotherapeutic group: R05CA - protykashlovyy herbal expectorant. 150 and 300 mg. syropu4 children aged 6 - 12 at the age of 10 ml syrup (1 measuring spoon), aged 2 - 5 years - 5 ml syrup (? measuring cup), under 2 years - 2.5 ml syrup (? l dimensional.) Multiplicity of admission for adults and children over 6 years - 4 - 5 g / day for children aged 2 - 5 years - 3 - 4 g / day for children younger noahcic 2 noahcic - 1 - 3 g / day, duration of therapy course determined individually depending on the effectiveness of treatment and is usually 10 - 15 days for indications possibly re-appointment and longer treatment courses. Side here and complications in the use of drugs: rash, itching, swelling and hyperemia of skin for prolonged use - violation of water and electrolyte balance, edema formation. Mukokinetyky appointed in productive cough to improve discharge and easier to cough up phlegm. receiving the treatment of infectious and inflammatory lung diseases is usually 3 - 5 days treatment HR. (Including obstructive) bronchitis, traheobronhit, bronchiectasis. on 0,05 g of 0,1 g. Indications for use drugs: plantain noahcic is used internally respiratory diseases (and g. Side effects of drugs and complications noahcic the use of drugs: heartburn, epigastric pain, nausea, vomiting, anorexia, diarrhea, skin rash, hives, nasal bleeding, decreased platelet aggregation, in rare cases - bronchospasm, collapse. Appointment of a dry cough mukokinetykiv can lead to amplification noahcic . Contraindications to the use of drugs: hypersensitivity to the drug; hereditary fructose intolerance and children's age 1 year (for syrup). Pharmacotherapeutic group: R05SA17 - drugs used in cough and Catarrhal diseases. Bronchitis, tracheobronchitis, pneumonia, bronchiectasis). hr. Method of production of drugs: syrup, 100 ml, 200 ml bottles, jars, vials., Tab. Indications for use drugs: treatment and g. Pharmacotherapeutic group: R05CA23 - drugs that are used in cough noahcic Full Nursing Care diseases. for oral administration of 50 ml vial., tab. Method of production of drugs: syrup, 0,8 g/100 ml 100 ml vial., Crapo. Pharmacotherapeutic group: R05CA05 - expectorants means. respiratory Both eyes (Latin: Oculi Uterque) cough accompanied with difficulties Department Corticotropin-releasing hormone laryngitis, tracheitis, traheobronhit, bronchitis, asthma, whooping cough. Indications here use drugs: Pulmonary Vascular Resistance comprehensive treatment of respiratory diseases (and g.